J. Crossley

发表

Circulating Angiogenic Factors in Early Pregnancy and the Risk of Preeclampsia, Intrauterine Growth Restriction, Spontaneous Preterm Birth, and Stillbirth

Gordon C. S. Smith, F. Lyall, J. Connor, 2007, Obstetrics and gynecology.

Pregnancy-Associated Plasma Protein A and Alpha-fetoprotein and Prediction of Adverse Perinatal Outcome

J. Pell, Gordon C. S. Smith, I. Shah, 2006, Obstetrics and gynecology.

Is maternal serum total hCG a marker of trisomy 21 in the first trimester of pregnancy?

K. Nicolaides, K. Spencer, J. Crossley, 2000, Prenatal diagnosis.

Circulating Angiogenic Factors in Early Pregnancy and the Risk of Preeclampsia, Intrauterine Growth Restriction, Spontaneous Preterm Birth, and Stillbirth

Gordon C. S. Smith, F. Lyall, J. Connor, 2006, Obstetrics and gynecology.

Letter. Response to: Wald, N.J. and Hackshaw, A.K. (1997). Combining ultrasound and biochemistry in first‐trimester screening for Down's syndrome, Prenat. Diagn., 17, 821–829

K. Spencer, T. Reynolds, D. Krantz, 1998 .

Screening for Down's syndrome in the first trimester: Combined risk calculation, methodology, and validation of a web‐based system

M. Kublickas, J. Crossley, D. Aitken, 2009, Acta obstetricia et gynecologica Scandinavica.

Second‐trimester levels of pregnancy‐associated plasma protein‐A and free β‐hCG in pregnancies with trisomy 13

K. Nicolaides, K. Spencer, J. Crossley, 2005, Prenatal diagnosis.

Frequency and clinical consequences of extremely high maternal serum PAPP‐A levels

K. Spencer, H. Cuckle, F. Muller, 2003, Prenatal diagnosis.

Maternal serum total hCG and free β‐hCG in the first trimester from trisomy 21 pregnancies

K. Spencer, J. Crossley, D. Aitken, 2000, Prenatal diagnosis.

Second trimester levels of pregnancy associated plasma protein‐A in cases of trisomy 18

K. Spencer, J. Crossley, D. Aitken, 1999, Prenatal diagnosis.

Urinary free beta hCG, beta core fragment and total oestriol as markers of Down syndrome in the second trimester of pregnancy

K. Spencer, J. Hsu, J. Crossley, 1999, Prenatal diagnosis.

Screening for Down's syndrome: changes in marker levels and detection rates between first and second trimesters

J. Connor, J. Crossley, D. Aitken, 1997, British journal of obstetrics and gynaecology.

First‐trimester biochemical screening for fetal chromosome abnormalities and neural tube defects

K. Spencer, J. Connor, J. Crossley, 1993, Prenatal diagnosis.

Estimating the risk of a fetal autosomal trisomy at mid‐trimester using maternal serum alpha fetoprotein and age: A retrospective study of 142 pregnancies

J. Yates, J. Crossley, D. Aitken, 1991, Prenatal diagnosis.

Factors limiting the effectiveness of prenatal screening for anencephaly and spina bifida in a high-risk area.

P. McLoone, D. Stone, J. Crossley, 1993, Paediatric and perinatal epidemiology.

Growth hormone binding protein in normal and aneuploid pregnancy: a paradoxical decrease in trisomy 18

T. Veveris-Lowe, E. Wallace, D. D'Antona, 2001, BJOG : an international journal of obstetrics and gynaecology.

Cross-trimester repeated measures testing for Down's syndrome screening: an assessment.

F. Malone, M. D'Alton, K. Spencer, 2010, Health technology assessment.

A. Horne, E. Wallace, N. Groome, 2022 .

Maternal obesity in early pregnancy and risk of spontaneous and elective preterm deliveries: a retrospective cohort study.

J. Pell, Gordon C. S. Smith, I. Shah, 2007, American journal of public health.

Second-trimester maternal serum levels of alpha-fetoprotein and the subsequent risk of sudden infant death syndrome.

J. Pell, I. White, A. Wood, 2004, The New England journal of medicine.

Maternal smoking: age distribution, levels of alpha‐fetoprotein and human chorionic gonadotrophin, and effect on detection of Down syndrome pregnancies in second‐trimester screening

J. Connor, J. Crossley, D. Aitken, 2002, Prenatal diagnosis.

[Unexplained increase in maternal plasma in alpha-fetoproteins in the second trimester of pregnancy: perinatal results].

J. Kingdom, M. McNay, A. Bowman, 1995, Revista chilena de obstetricia y ginecologia.

First-trimester placentation and the risk of antepartum stillbirth.

Jill P Pell, J. Pell, Gordon C. S. Smith, 2004, JAMA.

Linkage analysis using multiple Xq DNA polymorphisms in normal families, families with the fragile X syndrome, and other families with X linked conditions.

J. Yates, J. M. Connor, J. Crossley, 1987, Journal of medical genetics.

Second-trimester maternal serum levels of alpha-fetoprotein and the subsequent risk of sudden infant death syndrome.

Ian R White, Angela M Wood, Jill P Pell, 2004, New England Journal of Medicine.

Maternal and biochemical predictors of spontaneous preterm birth among nulliparous women: a systematic analysis in relation to the degree of prematurity.

J. Pell, I. White, Gordon C. S. Smith, 2006, International journal of epidemiology.

Second‐trimester unconjugated oestriol levels in maternal serum from chromosomally abnormal pregnancies using an optimized assay

J. Connor, J. Crossley, D. Aitken, 1993, Prenatal diagnosis.

Development: Early-pregnancy origins of low birth weight

Alan D. Cameron, David A. Aitken, Gordon C. S. Smith, 2002, Nature.

HEAT‐STABLE AND IMMUNOREACTIVE PLACENTAL ALKALINE PHOSPHATASE IN MATERNAL SERUM FROM DOWN'S SYNDROME AND TRISOMY 18 PREGNANCIES

J. Connor, J. Crossley, D. Aitken, 1996, Prenatal diagnosis.

Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.

A. Lyon, J. Connor, J. Connor, 1996, The New England journal of medicine.

First Trimester Biochemical Screening for Trisomy 21: The Role of Free Beta hCG, Alpha Fetoprotein and Pregnancy Associated Plasma Protein A

K. Spencer, J. Connor, J. Crossley, 1994, Annals of clinical biochemistry.

Analysis of maternal serum alpha‐fetoprotein and free beta human chorionic gonadotrophin in the first trimester: Implications for down's syndrome screening

J. Crossley, D. Aitken, J. Macri, 1995, Prenatal diagnosis.

First‐trimester combined ultrasound and biochemical screening for Down syndrome in routine clinical practice

J. Connor, J. Crossley, D. Aitken, 2004, Prenatal diagnosis.

Biochemical markers of trisomy 21 and the pathophysiology of Down's syndrome pregnancies

J. Connor, A. Howatson, J. Crossley, 1997, Prenatal diagnosis.

Variation in the levels of pregnancy‐ specific β‐1‐glycoprotein in maternal serum from chromosomally abnormal pregnancies

J. Connor, G. Graham, J. Crossley, 1992, Prenatal diagnosis.

Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha‐fetoprotein, and age

J. Connor, J. Crossley, D. Aitken, 1991, Prenatal diagnosis.

Dual Analyte Immunoassay in Neural Tube Defect and Down's Syndrome Screening: Results of a Multicentre Clinical Trial

K. Spencer, P. Wood, J. Crossley, 1993, Annals of clinical biochemistry.

Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth.

Gordon C. S. Smith, J. Connor, J. Crossley, 2002, The Journal of clinical endocrinology and metabolism.

Prenatal diagnosis and management of anterior abdominal wall defects in the West of Scotland

M. McNay, M. Whittle, J. Crossley, 1993, Prenatal diagnosis.

Maternal serum alpha‐fetoprotein levels in congenital nephrosis

J. Crossley, D. Aitken, J. Tolmie, 1997, Prenatal diagnosis.

The pathophysiology of Down's syndrome pregnancies.

J. Connor, A. Howatson, J. Crossley, 1996, Early human development.

Aneuploidy screening: a position statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, January 2011

L. Dugoff, K. Spencer, H. Cuckle, 2011, Prenatal diagnosis.

Second‐trimester pregnancy associated plasma protein‐A levels are reduced in Cornelia de Lange syndrome pregnancies

J. Burn, J. Connor, J. Crossley, 1999, Prenatal diagnosis.

Maternal obesity in early pregnancy and risk of spontaneous and elective preterm deliveries: a retrospective cohort study.

J. Pell, Gordon C. S. Smith, I. Shah, 2007, American journal of public health.

Reliability of self reported smoking status by pregnant women for estimating smoking prevalence: a retrospective, cross sectional study

D. Tappin, D. Shipton, J. Chalmers, 2009, BMJ : British Medical Journal.

Evolution of an Inhibin a ELISA Method: Implications for Down's Syndrome Screening

K. Spencer, E. Wallace, N. Groome, 1998, Annals of clinical biochemistry.

Maternal serum inhibin‐A in pregnancies complicated by insulin dependent diabetes mellitus

E. Wallace, N. Groome, J. Crossley, 1997, British journal of obstetrics and gynaecology.

Impact of a Regional Screening Programme Using Maternal Serum a Fetoprotein (AFP) and Human Chorionic Gonadotrophin (hCG) on the Birth Incidence of Down's Syndrome in the West of Scotland

J. Connor, J. Crossley, D. Aitken, 1994, Journal of medical screening.

Combined ultrasound and biochemical screening for Down's Syndrome in the first trimester: a Scottish multicentre study

J. Connor, J. Crossley, D. Aitken, 2002, BJOG : an international journal of obstetrics and gynaecology.

Amniotic fluid inhibin-A in chromosomally normal and Down's syndrome pregnancies.

E. Wallace, N. Groome, J. Crossley, 1997, The Journal of endocrinology.

The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome

K. Spencer, F. Dunstan, J. Crossley, 2003, Annals of clinical biochemistry.

INSULIN‐DEPENDENT DIABETES MELLITUS AND PRENATAL SCREENING RESULTS: CURRENT EXPERIENCE FROM A REGIONAL SCREENING PROGRAMME

J. Connor, J. Crossley, D. Aitken, 1996 .

Inhibin‐B and pro‐αC‐containing inhibins in amniotic fluid from chromosomally normal and Down syndrome pregnancies

E. Wallace, S. Riley, J. Crossley, 1998 .

First‐trimester contingent screening for Down syndrome can reduce the number of nuchal translucency measurements required

J. Crossley, D. Aitken, T. Vadiveloo, 2009, Prenatal diagnosis.

Uncertainty in nuchal translucency reference ranges at 11–14weeks of gestation – comparison to Swedish centiles

C. Grunewald, M. Kublickas, H. Almström, 2011, Acta obstetricia et gynecologica Scandinavica.

Deriving risks of Down's syndrome from nuchal translucency measurements

J. Crossley, D. Aitken, 1999, Ultrasound in Obstetrics and Gynecology.

Screening for chromosome abnormalities

J. Crossley, D. Aitken, 1992 .

Amniotic fluid alpha‐fetoprotein, gamma‐glutamyltranspeptidase, and autosomal trisomies

M. Ferguson-Smith, G. Graham, J. Crossley, 1989, Prenatal diagnosis.

Second trimester levels of pregnancy associated plasma protein‐A in cases of trisomy 18

K. Spencer, J. Crossley, D. Aitken, 1999, Prenatal Diagnosis.

Maternal and biochemical predictors of antepartum stillbirth among nulliparous women in relation to gestational age of fetal death

Gordon C. S. Smith, I. Shah, R. Dobbie, 2007, BJOG : an international journal of obstetrics and gynaecology.